Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Life Science • Mobile |
Investing | China |
Investment Range | $44,000,000 - $44,000,000 |
Cenova Capital is a venture capital firm headquartered in Shanghai, China, specializing in the life sciences and healthcare sectors. Founded in 2010, it stands as one of the pioneering healthcare funds in the region, focusing on early and growth-stage investments. With five funds under management, Cenova has invested in over 50 companies, spanning healthcare services, pharmaceuticals, medical devices, and digital health sectors. Their investor base comprises mainly large domestic and international institutional investors, including Asian sovereign wealth funds, government institutions, insurance, financial institutions, and multinational companies. Cenova employs a distinguished investment strategy that capitalizes on leveraging its healthcare services portfolio to tap into adjacent opportunities within the sub-sector of healthcare products and services. As a value-oriented investor, a methodical, research-based approach is utilized to uncover unique proprietary investment opportunities. The portfolio includes synergistic, highly profitable investments in various healthcare service areas such as IVF, maternity, ENT, ophthalmology, and aesthetics/plastic surgery. Cenova's core values, which include integrity, respect, teamwork, and diligence, shape their corporate philosophy. Advocating the principles of prioritizing customer interests and dedication to performance and returning capital to investors, Cenova aims to become the leading healthcare fund in China and the partner of choice for healthcare companies and investors targeting the rapidly growing Chinese healthcare market. Their investment thesis revolves around a deep commitment to innovating within China's healthcare transformation, substantiated by robust investments in the software, IT, media, biotech, hardware, health tech, blockchain, medical devices, real estate, life science, and mobile industries. The firm's investment range is defined by a minimum and maximum of $44,000,000 dedicated to fostering the growth of promising enterprises within these sectors.